WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Murdo Gordon Biography and Net Worth

EVP of Amgen

Murdo Gordon is executive vice president, Global Commercial Operations for Amgen. In this role, which he assumed in September 2018, Gordon is responsible for ensuring Amgen’s innovative medicines reach patients around the world.

Prior to joining Amgen, Gordon served in a variety of leadership positions during a nearly 30-year career at Bristol-Myers Squibb (BMS). His last role there was Chief Commercial Officer with responsibility for commercial strategy globally, including all sales and marketing activities, as well as customer operations, access and pricing. Previously, Gordon served as head of worldwide markets with responsibility for the promotion of all BMS brands globally. This was preceded by his work as president of BMS’ U.S. operations, a role he assumed in 2013.

Gordon joined BMS in 1989 and spent the first 14 years of his career in Canada, after receiving a Bachelor of Science in Cell and Molecular Biology from Concordia University, Montreal. In addition, he participated in the General Management Program, CEDEP at INSEAD, Fontainebleau, France.

What is Murdo Gordon's net worth?: The estimated net worth of Murdo Gordon is at least $11.67 million as of August 10th, 2023. Mr. Gordon owns 44,308 shares of Amgen stock worth more than $11,669,841 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Gordon may own. Additionally, Mr. Gordon receives a salary of $3,240,000.00 as EVP at Amgen. Learn More about Murdo Gordon's net worth.
How old is Murdo Gordon?: Mr. Gordon is currently 57 years old. There are 7 older executives and no younger executives at Amgen. The oldest executive at Amgen is Mr. Peter H. Griffith, Executive VP & CFO, who is 65 years old. Learn More on Murdo Gordon's age.
What is Murdo Gordon's salary?: As the EVP of Amgen Inc., Mr. Gordon earns $3,240,000.00 per year. There are 2 executives that earn more than Mr. Gordon. The highest earning executive at Amgen is Mr. Robert A. Bradway, Chairman & Chief Executive Officer, who commands a salary of $6,730,000.00 per year. Learn More on Murdo Gordon's salary.
How do I contact Murdo Gordon?: The corporate mailing address for Mr. Gordon and other Amgen executives is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. Amgen can also be reached via phone at (805) 447-1000 and via email at [email protected]. Learn More on Murdo Gordon's contact information.
Has Murdo Gordon been buying or selling shares of Amgen?: Murdo Gordon has not been actively trading shares of Amgen in the last ninety days. Most recently, Murdo Gordon sold 9,558 shares of the business's stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $262.43, for a transaction totalling $2,508,305.94. Following the completion of the sale, the executive vice president now directly owns 44,308 shares of the company's stock, valued at $11,627,748.44. Learn More on Murdo Gordon's trading history.
Who are Amgen's active insiders?: Amgen's insider roster includes Robert Bradway (Chairman & Chief Executive Officer), Robert Eckert (Director), Murdo Gordon (EVP), Jonathan Graham (EVP), Peter Griffith (Exec. VP & CFO ), Nancy Grygiel (SVP), Nancy Grygiel (SVP), Ronald Sugar (Director), Ronald Sugar (Director), and R Williams (Director). Learn More on Amgen's active insiders.
Are insiders buying or selling shares of Amgen?: During the last year, insiders at the medical research company sold shares 1 times. They sold a total of 2,117 shares worth more than $662,811.53. The most recent insider tranaction occured on May, 3rd when SVP Nancy A Grygiel sold 2,117 shares worth more than $662,811.53. Insiders at Amgen own 0.7% of the company. Learn More about insider trades at Amgen.
Information on this page was last updated on 5/3/2024.

Murdo Gordon Insider Trading History at Amgen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/10/2023	Sell	9,558	$262.43	$2,508,305.94	44,308

Murdo Gordon Buying and Selling Activity at Amgen

Amgen Company Overview

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Today's Range

Now: $263.38

$262.21

$269.61

50 Day Range

MA: $296.20

$258.78

$325.28

2 Week Range

Now: $263.38

$253.30

$346.85

Volume

13,504,368 shs

Average Volume

2,692,987 shs

Market Capitalization

$141.58 billion

P/E Ratio

33.72

Dividend Yield

3.38%

Beta

0.55

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Murdo Gordon Biography and Net Worth

What is Murdo Gordon's net worth?

How old is Murdo Gordon?

What is Murdo Gordon's salary?

How do I contact Murdo Gordon?

Has Murdo Gordon been buying or selling shares of Amgen?

Who are Amgen's active insiders?

Are insiders buying or selling shares of Amgen?